Amer Zeidan: Looking forward to finding cures for all AML and MDS patients

Amer Zeidan shared on X:

“Looking forward to finding cures for all Acute Myeloid Leukemia and Myelodysplastic Syndromes patients through collaborations across the Atlantic and across the world.

What an amazing community of hardworking and dedicated researchers and physicians at EHA2024 Onward and forward!”.

Source: Amer Zeidan/X

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center.

Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.